Current situation and Prospect of the hottest phar

2022-08-16
  • Detail

Current situation and Prospect of pharmaceutical glass packaging in China (Part 1)

pharmaceutical glass is a major branch of the pharmaceutical packaging industry, and it is also an important part of the entire pharmaceutical industry. Since the reform and opening up, China's pharmaceutical glass packaging industry has developed rapidly, especially through the efforts during the "Eighth Five Year Plan" and "Ninth Five Year Plan", it can basically meet the needs of pharmaceutical packaging, and is developing into a pivotal industry

in order to facilitate relevant people to have a relatively clear understanding and positioning of the current situation and development prospects of China's pharmaceutical glass packaging, shorten the gap with the international advanced level as soon as possible, meet the opportunities and challenges brought by the establishment of macro-control and market conditioning mechanism after China's entry into WTO to the pharmaceutical glass industry, and promote the improvement of the overall level of China's pharmaceutical preparations, This paper briefly reviews the main pharmaceutical glass packaging involved in several dosage forms

I. antibiotic powder injection bottles

antibiotic powder injection bottles are mainly divided into two types: molding and control

molded antibiotic bottles: these products are widely used in the packaging of antibiotic powder injections, and the dosage is about 70% of the total amount of antibiotic powder injections. Harbin Pharmaceutical Group, Lukang Pharmaceutical Group and Shijiazhuang Pharmaceutical Group, among the "four giants" of domestic antibiotic subpackaging, basically use molded antibiotic bottles, with an annual consumption of about 4billion

in recent years, with the rapid development of the pharmaceutical industry, the manufacturing process and product quality of this product have been greatly improved. Shandong Pharmaceutical Glass Co., Ltd., the largest manufacturer in China, in order to narrow the gap with similar products in foreign developed countries as soon as possible, while expanding its scale, it pays attention to accelerating the pace of technological transformation and increasing the investment in technological transformation. In 1997, it introduced a bottle making production line from Emhart of the United States, whose product quality level has reached and approached the advanced level of similar products in the world, Through the continuous innovation and transformation of the original process technology and equipment, the enterprise trial produced thin-walled lightweight bottles and high white material bottles, which improved the transparency and smoothness of the bottle appearance

at present, there are 10 molded antibiotic bottle manufacturers in China, with an annual output of about 10billion bottles, and the annual output of most enterprises is less than 500million bottles. There is still a big gap between the level of technical equipment and the level of product quality and the advanced level of similar international products. The task of lightweight has not been fully realized. The traditional 800000 units of penicillin are increasingly replaced by large-dose sub packaging, and various new special drugs and high-end drugs appear, In addition to the competition of tube bottles, molded antibiotic bottles will face the development trend of lightweight, high-grade and large-scale standardization

controlled antibiotic bottles: North China Pharmaceutical Co., Ltd. is the largest user of these products in China, with an annual consumption of about 1.2 billion bottles. This product has developed rapidly in recent years, and has gradually replaced ampoules for freeze-drying agents, and partially replaced molded bottles. It is simple to operate. The tube bottle is a secondary processing product, and its quality level depends not only on the manufacturing process, but also on the quality level of the glass tube. If the accuracy of the strain gauge is not high, or the anti-aging ability of the glue used to fix the strain gauge is not good, or the material of the sensor is not good, the accuracy and service life of the sensor will be affected. Therefore, enterprises with glass tube production capacity should have certain advantages, but at present, many domestic manufacturers do not have tube drawing production capacity, resulting in large differences in product quality and fierce market competition. Compared with similar international products, there is also a certain gap in the material of glass. In addition, the product standard level, physical quality level and packaging quality have not reached the advanced level of similar international products

judging from the development trend of antibiotic powder injection at home and abroad around 1901, this product will have great development potential. Improving glass material, increasing bottle strength, improving the stability of specification and size, appearance quality and packaging quality, and developing controlled bottles with low expansion coefficient and printing will become the development direction in the future. The pharmaceutical industry put forward in the development guidelines, policies and objectives to 2010: "the output targets of the five preparations are expected to be: the sub packaging volume of antibiotics will increase by 10% per year, with an output of 13billion bottles in 2000 and about 21billion bottles in 2010." Antibiotic powder injection is one of the "five dosage forms" of drugs. Among all kinds of conventional drugs, the dosage of antibiotics is the largest

from the analysis of international and domestic market status and development needs, the consumption of controlled bottles has a gradual upward trend, but molded bottles have always occupied the leading position, and more than 70% of antibiotic powder injections are still packaged in molded bottles

the outline of the "Tenth Five Year Plan" for the development of pharmaceutical packaging industry puts forward in the development direction of each dosage form packaging: "powder injection (including biological and biochemical freeze-drying) We should develop high-quality controlled bottles and light-weight molded bottles. For a long time to come, these two types of products will give full play to their unique advantages in the fierce market competition, and will inevitably compete and replace each other in the development, and achieve greater development in the mutual substitution competition. "

Copyright © 2011 JIN SHI